Difference between revisions of "Team:Georgia State/Design"

Line 29: Line 29:
 
                 <div class="site-header">
 
                 <div class="site-header">
 
                     <div class="logo">
 
                     <div class="logo">
                         <h1>Design/Description</h1>
+
                         <h1>Design</h1>
 
                     </div>
 
                     </div>
  
Line 64: Line 64:
 
                 <ul class="dropdown-menu">
 
                 <ul class="dropdown-menu">
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Parts">Parts</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Parts">Parts</a></li>
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Design">Design</a></li>     
+
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/PartsDesign">Design</a></li>     
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Contribution">Contribution</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Contribution">Contribution</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Improve">Improvement</a></li>
 
                                 <li><a href="https://2017.igem.org/Team:Georgia_State/Improve">Improvement</a></li>
Line 107: Line 107:
 
             <option value="/Team:Georgia_State/Collaborations">Collaborations</option>
 
             <option value="/Team:Georgia_State/Collaborations">Collaborations</option>
 
             <option value="/Team:Georgia_State/Parts">Parts</option>
 
             <option value="/Team:Georgia_State/Parts">Parts</option>
             <option value="/Team:Georgia_State/Design">Design</option>
+
             <option value="/Team:Georgia_State/PartsDesign">Parts Design</option>
 
             <option value="/Team:Georgia_State/Contribution">Contribution</option>
 
             <option value="/Team:Georgia_State/Contribution">Contribution</option>
 
             <option value="/Team:Georgia_State/Improvement">Improve</option>
 
             <option value="/Team:Georgia_State/Improvement">Improve</option>
Line 125: Line 125:
 
             </div>
 
             </div>
 
<!-- Menu End -->
 
<!-- Menu End -->
 +
  
 
  <div class="container">
 
  <div class="container">
 
                 <div class="featured-heading">
 
                 <div class="featured-heading">
                     <h1><i><font style="text-transform: none;">"The unassuming horseshoe crab is indispensable to human health."</font></i></h2>
+
                     <h1><i><font style="text-transform: none;">"As soon as your brain starts telling you that you can't have a tree that is blue then you stop being able to paint trees."</font></i></h2>
                     <h2>John Essex</h4>
+
                     <h2>Steven Johnson</h4>
 
                                     </div>
 
                                     </div>
 
             </div>
 
             </div>
     
 
<html>
 
<br>
 
<h1 style="color:#1F618D; text-align: center; font-size: 36px; line-height: 40px;">Background</h1>
 
<br>
 
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">The Target: Endotoxin Contamination of Medical Supplies</h1>  <br>
 
"Endotoxin" is often used as a general term to describe any bacterial toxin, but is more properly used to describe components of the cell surface of Gram-negative bacteria, particularly the lipopolysaccharide complex.  Lipopolysaccharide (LPS) is composed of a core oligosaccharide, O-antigen a glycan polymer and Lipid A. The lipid component, Lipid A is a phosphorylated glucosamine disaccharide with multiple fatty acids and is the primary cause for endotoxin toxicity.  When gram-negative bacteria enter the human body a complement immune response is initiated. Once the cell wall and/or bacteria are destroyed  endotoxins are released which can lead to endotoxemia, the symptoms of which are vomiting, nausea, diarrhea, fever, disseminated intravascular coagulation, vascular collapse, organ failure and possibly death. Antibiotics will not inactivate the endotoxins, therefore detection of the endotoxin before they enter the body is prudent.<br>
 
<br>
 
 
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">What do horseshoe crabs have to do with endotoxin?</h1>  <br>
 
</h1> 
 
<br>
 
 
<img src="https://static.igem.org/mediawiki/2017/c/cf/T--Georgia_State--horseshoebranfromaquarium.jpg"  alt="Horseshoe Crab in Aquarium" width="250" height="250" style="float:right;">
 
 
<b> Limulus polyphemus (Atlantic horseshoe crab)</b> is protected against infection by its immune system and blood coagulation system. Because they are invertebrates, horseshoe crab circulatory and immune systems are very different from those seen in vertebrate animals. Horseshoe crabs use hemocyanin to carry oxygen instead of hemoglobin. The blue color of their blood is due to the presence of copper in hemocyanin. In place of the complex leukocyte array that make up the human immune response, horseshoe crabs rely on circulating amebocytes to detect and respond to pathogens. Inside the amebocytes are proteins that are released in response to unwanted organisms like gram-negative bacteria. These proteins bind to and inactivate endotoxin. Assistance in wound control is moderated by components of their blood which prevent bleeding and form a physical barrier against additional infection. <br>
 
In the presence of endotoxin, a clotting cascade is invoked to activate the proclotting enzyme which is used to transform coagulogen into coagulin. The first step in this cascade involves activation of zymogen Factor C, a 123 kDa glycoprotein that becomes enzymatically active in the presence of bacterial endotoxin. Factor C consists of an H chain (80kD) and L chain (43kD); in the presence of LPS the enzyme becomes active and undergoes autocatalysis, the phenylalanine- isoleucine bond on the L chain is cleaved resulting in a B chain (34kD) and an A chain (8.5 kD). Activated Factor C then activates Factor B which activates the proclotting enzyme. The  activated proclotting enzyme then converts coagulogen into coagulin, resulting in a clotting-like reaction which isolates the bacterial pathogen. <br>
 
 
 
  
  
<img src="https://static.igem.org/mediawiki/2017/9/9a/T--Georgia_State--FactorCcascade.jpg"  alt="Cotting Cascade" width="300" height="300" style="left;">
 
  
<img src="https://static.igem.org/mediawiki/2017/1/1d/T--Georgia_State--factorcdiagram.jpg"  alt="Factor C diagram" width="250" height="250" style="float:right;">  
+
<br>
 +
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Limulus Factor C cDNA Design</h1>  <br>
 
<br>
 
<br>
  
  
 +
<b>Limulus Factor C </b>is a relatively large protein (1020 amino acids), so the synthesis of its coding sequence presented a challenge. We determined that instead of trying to have the entire construct synthesized as one piece it would be more cost effective to build it in pieces. The coding sequence for Limulus Clotting Factor C (LFC) was designed as four contiguous blocks to be joined together via overlap extension PCR. Three of the four blocks were 800 bp long; the fourth block was 660 bp long. We designed primers for overlap extension PCR to join the g-blocks together into the final Factor C cDNA sequence. Primers were designed in both forward and reverse complement to the top and bottom strands of the blocks. For example, the forward primer of Block 2 was created with a few base pairs from Block 1 5’ top strand end. These base pairs were added to the beginning of the 5’ top strand to start amplification of Block 2’s top strand. The reverse complement primer for Block 1 was created by taking a few base pairs from the end of the 3’ bottom strand of Block 1 and adding it to the bottom strand of Block 2. The goal of creating these primers is to create overhangs from the previous block to bind to the next block. During amplification, the blocks would then be joined and extend the 5’ top strand and 3’ bottom strand of each block. Once all four blocks and a total of 8 primers were created, we began PCR amplification of Blocks 1 and 2 and then amplified Blocks 3 and 4. The fusion of the coupled blocks would then be fused together to make the final product, LFC Blocks 1-4 via overlap extension PCR.
 +
<br><br>
 +
<img src="https://static.igem.org/mediawiki/2017/2/25/T--Georgia_State--7.20OverlapFACTORCMAP.jpg"  alt="Horseshoe Crab in Aquarium" width="800" height="250" style="float:right;">
  
<br><br> <br>  
+
<img src= "https://static.igem.org/mediawiki/2017/d/d1/T--Georgia_State--7.20OverlapDIAGRAM.jpg" alt="Clotting Cascade" width="300" height="100" style="left;">
 +
<br> <br>  
 +
<b> PCR Overlap Extension</b>
 +
due to the expense of purchasing the entire Factor C sequence as a new part and the opportunity to attempt a method that has never been done in the Georgia State University iGEM lab Factor C is planned to be synthesized via overlap extension PCR. A modified protocol written by Ichiro Matsumura was used. This method uses PCR to recombine DNA sequences instead of using restriction sites. By using a 3'-end primer that matches each template block and a 5'-end primer that matches a part of the block sequence and a part of the new block sequence. The two blocks can be recombined using DNA polymerase. The basic mechanism for overlap begins with a PCR to generate the two fragments (AB and CD)  that have ends modified by mispriming so that they have homologous regions. Through mixture, denaturation, and reannealing the AB 3'-end will anneal onto the 3'-end of the bottom strand of the CD. Extension of the overlap product is used to form the recombinant product (the overlapping ends of the fragments are created by primers b and c while a and d match the individual fragments). The method can be repeated to add together more than two DNA fragments.
 +
The image above and to the left is a figure to illustrate the mechanism described above.
  
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS"> The Current Method: The LAL Assay </h1>   
+
<br> <br>
 +
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Human Chorionic Gonaditropin</h1>  <br>
 +
When designing this part we used the recombinant cDNA sequence. While the same amino acids are present, the cDNA sequence is altered. To detect the activation of Factor C autocatalysis, a hCG-beta subunit sequence component was a necessary addition to our final Factor C cDNA sequence. Similar to the primers designed for Factor C, we designed a forward and a reverse complement primer with iGEM prefix and suffix to join Block 4 of Factor C and Block 5 of hCG-beta subunit together. For our idea of a detection system, we plan to use a pregnancy test to detect the recombinant hCG-beta subunit once Factor C is activated.
 
<br>  
 
<br>  
<img src= "https://static.igem.org/mediawiki/2017/2/24/T--Georgia_State--LALcascadeandBLUEblood.jpg" alt="Clotting Cascade" width="300" height="300" style="float:right;">
+
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Factor C-hCG Fusion </h1>  
 
+
Injectable healthcare products such as vaccines and any other healthcare products such as implantables that come into contact with a patient's blood or cerebrospinal fluid must be sterile. However, processes that kill bacteria may still result in the release of endotoxin into the product. Medical products must be tested for endotoxicity before use. The Limulus Amebocyte Lysate test uses an extract of the Limulus polyphemus (Atlantic horseshoe crab) blood cells (amoebocytes) to detect small concentrations of endotoxin that may contaminate medical supplies.  To obtain the extract, Horseshoe crabs are bled through the pericardium. A third of their blood is taken and they are released back into the water. Through centrifugation, their blood cells are separated from the serum. In order to release the chemicals from inside the blood cells, they are placed in distilled water where they burst and form the lysate. A sample is mixed with lysate and water and presence of endotoxin can be assayed by the coagulation response.
+
<br>
+
 
+
<br>
+
<iframe width="450" height="230" align= "float" src="https://www.youtube.com/embed/VgEbcQxFUu8" frameborder="0" allowfullscreen> </iframe>
+
<img src= "https://static.igem.org/mediawiki/2017/5/52/T--Georgia_State--horseshoecrabbleeding.jpg" alt="horseshoe crab bleeding" width="350" height="450" style="float:right;">
+
 
+
<br>
+
 
+
<br>
+
 
+
</h1>
+
 
+
 
+
<h1 style="color:#ffffff; background-color:#1F618D;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">A Synthetic Biology Alternative to Bleeding Horseshoe Crabs </h1> 
+
<br>
+
+
Using horseshoe crab blood is an unsustainable practice due to the impact on the crabs and the expense of the LAL assay. A third of the blood is taken from the horseshoe crab before they are released back into the water. In theory the crabs recover from this draining, however up to 30% of bled crabs die. The total population is decreasing rapidly while producers are forced to increase harvests to keep up with global demand. The LAL test is expensive: a quart of blood is sold for $15,000. Part of affordable healthcare means that the production of the products used also need to be affordable. <br>
+
Creating an alternative form of testing using synthetic biology would alleviate both the impact on the horseshoe crabs and the overall cost of healthcare. Instead of creating a recombinant version of the entire clotting cascade we think it is more efficient to create a recombinant version of Factor C that includes a signaling mechanism to detect autocatalysis in the presence of LPS.  We've chose to design a fusion protein that combines recombinant Factor C with the Human chorionic gonadotropin (hCG) beta subunit. Because hCG is easily detected with a human pregnancy test we expect that we can detect autocatalysis of the Factor C-hCG fusion protein using an inexpensive, easy-to-interpret, and portable system . The goal of our project is to create a fusion protein of Factor c with hCG and immobilize it on a solid substrate such as nylon membrane. The immobilized protein can then be exposed to the fluid to be tested; if LPS is present the Factor C fusion protein will undergo autocatalysis and release hCG into the solution where it is then detected by the pregnancy test. <br>
+
 
+
<img src= "https://static.igem.org/mediawiki/2017/4/4b/T--Georgia_State--factorcdiagrampart1.jpg" alt="factorc1" width="350" height="450" style="float:left;">
+
<img src= "https://static.igem.org/mediawiki/2017/a/a3/T--Georgia_State--factorc2.jpg" alt="factorc1" width="350" height="450" style="float:right;">
+
<br><br><br> <br> <br> <br>
+
<br> <br> <br><br> <br>
+
<h1>
+
<a href="https://2017.igem.org/Team:Georgia_State/PartsDesign"><h1 style="color:#ffffff; background-color:#7FB3D5;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Next: Parts</h1></a>
+
<ul class="img-home">
+
 
+
 
+
 
<br><br>
 
<br><br>
<a href="https://2017.igem.org/Team:Georgia_State"><h1 style="color:#ffffff; background-color:#A9CCE3;; -moz-border-radius: 15px; -webkit-border-radius: 15px; padding:15px; text-align: center; font-family: Trebuchet MS">Back to Home</h1> </a>
 
 
 
<ol style="font-size: 8pt;">
 
<ol style="font-size: 8pt;">
 
<b>References</b><br>
 
<b>References</b><br>
- - -B. Akbar John, K.C.A. Jalal, Y.B. Kamaruzzaman and K. Zaleha, 2010.<i>Mechanism in the Clot Formation of Horseshoe Crab Blood during Bacterial Endotoxin Invasion (July 10, 2010). Journal of Applied Sciences, 10: 1930-1936. Retrieved June 11, 2017, from</i><a http://scialert.net/fulltext/?doi=jas.2010.1930.1936">http://scialert.net/fulltext/?doi=jas.2010.1930.1936</a> <br>
 
  
- - - <i>Elizabeth Cox. (2017,September, 21). Why do we harvest horseshoe crab blood?  [Video file]. </i> <a href="https://www.youtube.com/watch?v=VgEbcQxFUu8/"> https://www.youtube.com/watch?v=VgEbcQxFUu8/</a> <br>
+
- - -Horton, R. M., Cai, Z., Ho, S. N., Pease, L. R., & Mayo Clinic. (2013). <i>Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction. BioTechniques, 54(3), 129-130 . doi:10.2144/000114017</i><a https://www.biotechniques.com/multimedia/archive/00190/BTN_A_000114017_O_190204a.pdf ">https://www.biotechniques.com/multimedia/archive/00190/BTN_A_000114017_O_190204a.pdf </a> <br>
 +
CGB protein [Homo sapiens] - Protein - NCBI. (2003, October 7). Retrieved July 7 2017, from
  
- - - <i>Ecological Research & Development Group. (2013). <br> Horseshoe Crabs and Endotoxin Testing . . Retrieved October 31, 2017, from </i> <a href="http://www.horseshoecrab.org/med/sustainable.html"> http://www.horseshoecrab.org/med/sustainable.html</a><br>
 
  
- - - <i>Ecological Research & Development Group. (2013). [Copper Based "Blue blood" and Cascade of Enzymes and Proteins ]. </i> JRetrieved October 31, 2017, from<br> <a href="http://www.horseshoecrab.org/med/testing.html">http://www.horseshoecrab.org/med/testing.html</a><br>
+
- - - <i>CGB protein [Homo sapiens] - Protein - NCBI. (2003, October 7).<br> Retrieved July 7 2017, from </i> <a href="https://www.ncbi.nlm.nih.gov/protein/26996824?report=genbank&log%24=protalign&blast_rank=1&RID=PU2MZS8Z014"> https://www.ncbi.nlm.nih.gov/protein/26996824?report=genbank&log%24=protalign&blast_rank=1&RID=PU2MZS8Z014</a><br>
  
- - - <i>PBS. (2014, February 26). A still for the PBS Nature documentary Crash [Digital image]. Retrieved October 31, 2017, from <br><a href="https://www.theatlantic.com/technology/archive/2014/02/the-blood-harvest/284078/">https://www.theatlantic.com/technology/archive/2014/02/the-blood-harvest/284078/</a><br>
+
- - - <i>P28175 (LFC_TACTR) Tachypleus tridentatus (Japanese horseshoe crab). (n.d.). Retrieved June 21, 2017, from  
 +
</i> <br> <a href=" https://swissmodel.expasy.org/repository/uniprot/P28175?csm=5BC2864C6715289B"> https://swissmodel.expasy.org/repository/uniprot/P28175?csm=5BC2864C6715289B</a><br>
  
 
+
<br>
 
+
</div>
</ol>
+
 
+
 
+
 
+
 
+
 
+
</html>
+

Revision as of 01:17, 2 November 2017


Limulus Factor C cDNA Design



Limulus Factor C is a relatively large protein (1020 amino acids), so the synthesis of its coding sequence presented a challenge. We determined that instead of trying to have the entire construct synthesized as one piece it would be more cost effective to build it in pieces. The coding sequence for Limulus Clotting Factor C (LFC) was designed as four contiguous blocks to be joined together via overlap extension PCR. Three of the four blocks were 800 bp long; the fourth block was 660 bp long. We designed primers for overlap extension PCR to join the g-blocks together into the final Factor C cDNA sequence. Primers were designed in both forward and reverse complement to the top and bottom strands of the blocks. For example, the forward primer of Block 2 was created with a few base pairs from Block 1 5’ top strand end. These base pairs were added to the beginning of the 5’ top strand to start amplification of Block 2’s top strand. The reverse complement primer for Block 1 was created by taking a few base pairs from the end of the 3’ bottom strand of Block 1 and adding it to the bottom strand of Block 2. The goal of creating these primers is to create overhangs from the previous block to bind to the next block. During amplification, the blocks would then be joined and extend the 5’ top strand and 3’ bottom strand of each block. Once all four blocks and a total of 8 primers were created, we began PCR amplification of Blocks 1 and 2 and then amplified Blocks 3 and 4. The fusion of the coupled blocks would then be fused together to make the final product, LFC Blocks 1-4 via overlap extension PCR.

Horseshoe Crab in Aquarium Clotting Cascade

PCR Overlap Extension due to the expense of purchasing the entire Factor C sequence as a new part and the opportunity to attempt a method that has never been done in the Georgia State University iGEM lab Factor C is planned to be synthesized via overlap extension PCR. A modified protocol written by Ichiro Matsumura was used. This method uses PCR to recombine DNA sequences instead of using restriction sites. By using a 3'-end primer that matches each template block and a 5'-end primer that matches a part of the block sequence and a part of the new block sequence. The two blocks can be recombined using DNA polymerase. The basic mechanism for overlap begins with a PCR to generate the two fragments (AB and CD) that have ends modified by mispriming so that they have homologous regions. Through mixture, denaturation, and reannealing the AB 3'-end will anneal onto the 3'-end of the bottom strand of the CD. Extension of the overlap product is used to form the recombinant product (the overlapping ends of the fragments are created by primers b and c while a and d match the individual fragments). The method can be repeated to add together more than two DNA fragments. The image above and to the left is a figure to illustrate the mechanism described above.

Human Chorionic Gonaditropin


When designing this part we used the recombinant cDNA sequence. While the same amino acids are present, the cDNA sequence is altered. To detect the activation of Factor C autocatalysis, a hCG-beta subunit sequence component was a necessary addition to our final Factor C cDNA sequence. Similar to the primers designed for Factor C, we designed a forward and a reverse complement primer with iGEM prefix and suffix to join Block 4 of Factor C and Block 5 of hCG-beta subunit together. For our idea of a detection system, we plan to use a pregnancy test to detect the recombinant hCG-beta subunit once Factor C is activated.

Factor C-hCG Fusion



    References
    - - -Horton, R. M., Cai, Z., Ho, S. N., Pease, L. R., & Mayo Clinic. (2013). Gene Splicing by Overlap Extension: Tailor-Made Genes Using the Polymerase Chain Reaction. BioTechniques, 54(3), 129-130 . doi:10.2144/000114017https://www.biotechniques.com/multimedia/archive/00190/BTN_A_000114017_O_190204a.pdf
    CGB protein [Homo sapiens] - Protein - NCBI. (2003, October 7). Retrieved July 7 2017, from - - - CGB protein [Homo sapiens] - Protein - NCBI. (2003, October 7).
    Retrieved July 7 2017, from
    https://www.ncbi.nlm.nih.gov/protein/26996824?report=genbank&log%24=protalign&blast_rank=1&RID=PU2MZS8Z014
    - - - P28175 (LFC_TACTR) Tachypleus tridentatus (Japanese horseshoe crab). (n.d.). Retrieved June 21, 2017, from
    https://swissmodel.expasy.org/repository/uniprot/P28175?csm=5BC2864C6715289B